Clinical Trial Update: Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a multi-epitope folate receptor alpha peptide vaccine with GM-CSF and cyclophosphamide for treating triple-negative breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Multi-epitope Folate Receptor Alpha Peptide Vaccine (not specified)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING